Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
Journal of the American Chemical Society
Page 2 of 5
macrocycle, for example, introduction of an α,βꢀ
unsaturated ketone or an epimeric allylic alcohol, abolꢀ
ish activity. Further, the side chain ketone was thought
to be essential and “proꢀdrug” ester derivatives affected
biofilm development at concentrations relative to their
rate of hydrolysis indicating that carolacton, and not the
analogs, were responsible for activity. Taken in sum,
earlier SAR work demonstrated that significant changes
to the macrocycle were not tolerated; however, it was
not clear if side chain modifications would be tolerated.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Our initial synthesis of carolacton was accomplished
in collaboration with the Phillips group in 2014.12 The
strategic design of our synthesis allowed for the lateꢀ
stage derivatization of the natural product scaffold to
elaborate on earlier SAR work – an approach referred to
as Diverted Total Synthesis (DTS) (Fig. 1).13 Both Danꢀ
ishefsky and Myers have beautifully applied DTS to the
development of novel anticancer14 and antibiotic15 comꢀ
pounds, respectively, with improved bioactivity. DTS
endeavors from our laboratory have uncovered new
phenotypes for the antibiotic promysalin16 and we
sought to use our initial total synthesis of carolacton
toward this end. We were inspired by the seminal work
of Chandrasekhar in their disclosure of simplified pladiꢀ
enolide analogs wherein they rigidified the side chain
with an aryl isostere and we determined that a similar
replacement was feasible based on computational modꢀ
eling (Fig. 1).17 We and others18 have been drawn to this
substitution as it would both simplify the synthesis and
effectively evaluate the importance of the elaborate side
chain. Herein we report the DTS of sixteen simplified
carolactonꢀinspired analogs which have resulted in the
discovery of three independent biofilm phenotypes: 1)
inhibition of their formation, 2) inhibition of their matuꢀ
ration, and 3) acidꢀmediated cell death during formation,
akin to carolacton, by an analog coined “carylacton”.
Scheme 1: Diverted Total Synthesis of Carolacton Analogs. (a) K2CO3,
MeOH/ THF, >99% (b) DMSO, (COCl)2, CH2Cl2. 94% (c) CuCN, Allylꢀ
MgBr, THF, 90% (d) 4Å MS, NaOH, PhMe, 83ꢀ85% (e) EDCI, DMAP,
CH2Cl2, 89ꢀ96% (f) Grubbs 2nd Generation Catalyst, CH2Cl2, 78ꢀ99% (g)
Pd/C, H2, 55ꢀ69% (h) TBAF, 64ꢀ94% (i) HCl, THF/MeOH, 50ꢀ82% (j)
DMSO, SO3.pyr, CH2Cl2, 63ꢀ89% (k) t-BuOH, 2ꢀmethylꢀ2ꢀbutene,
NaH2PO4, NaClO2, MeCN, H2O, 65ꢀ96% (l) TFA/ H2O, 59ꢀ79%
thylꢀderivative to interrogate the importance of chain
length. Toward this end, monoprotection followed by
oxidation of the corresponding 1,3ꢀdisubstituted benzene
diols provided the known compounds 4a/b. Roush croꢀ
tylation stereospecifically converts the benzylic aldeꢀ
hydes to the desired alcohols, furnishing structures 5a/b.
Leveraging our previous endgame strategy, an esterificaꢀ
tion united the side chain alcohols with acid 3. Finally,
cyclization using ringꢀclosing metathesis resulted in the
selective formation of the (E)-olefin, providing the fully
protected macrocyclic analog precursors 6a/b, which
can then be hydrogenated whereby the more sterically
accessible olefin is reduced providing 7a/b. Thus, these
four intermediates bearing the fully protected analog
skeleton represent the main branching points from which
we would synthesize our analog library.
It is well known that slight structural modifications
to macrolactones can result in significant biological outꢀ
comes;19 for example, the simple deletion of a methyl
group is enough to render a molecule inactive, as was
nicely demonstrated by the Andrade lab in their syntheꢀ
ses of desmethyl cethromycin.20 Based on these prior
reports, we sought to fully evaluate all desilyated comꢀ
pounds en route to “carylacton” to better understand the
SAR of such perturbations. We envisioned three logical
branching points that would facilitate the production of
four distinct scaffolds whereby we could evaluate the
role that the acetonide, olefin, and oxidation state play in
bioactivity. Facile deprotection of silylꢀethers 6 and 7
generate Scaffolds A and B, respectively, which differ
by an acetonide group. Scaffold A, bearing the primary
alcohol and acetonide, can then undergo a twoꢀstep oxiꢀ
dation, providing the corresponding acid found in Scaf-
fold C. Finally, the acetonide is treated with trifluoroaꢀ
cetic acid in water to furnish Scaffold D (Scheme 1). In
total, milligram quantities of sixteen analogs were synꢀ
thesized and further evaluated for their biological activiꢀ
ty in S. mutans UA159 assays described below.
Our first generation DTS library focused on conꢀ
serving the connectivity and stereochemistry of the
twelveꢀmembered macrolactone, but significantly simꢀ
plifying the carolacton side chain by introducing an aryl
moiety. We rationally selected 1,3ꢀdisubstituted aryl
motifs to mimic the trisubstituted olefin and chose to
vary both the length and oxidation state of the side
chain. This isosteric substitution would thereby elimiꢀ
nate five synthetic operations while maintaining the
structural integrity of the compound. Toward this end,
we optimized our previously published route to the key
intermediate, acid 3, which now proceeds in 36% overall
yield (a 50% improvement) and provides gramꢀ
quantities in under two weeks from commercial material
(Scheme 1, For more details see SI). With both a reliable
and scalable route to 3 in hand, we turned our attention
to the synthesis of the simplified side chains. We initialꢀ
ly chose two aryl diols to use as side chain precursors: a
pentyl moiety (closely mimicking carolacton) and a meꢀ
ACS Paragon Plus Environment